Pages that link to "Q35870795"

The following pages link to Antisense oligonucleotides in solution or encapsulated in immunoliposomes inhibit replication of HIV-1 by several different mechanisms (Q35870795):

Displaying 36 items.

• In vitro inhibition of hepatitis C virus gene expression by chemically modified antisense oligodeoxynucleotides (Q27477597) ‎ (← links)
• Lipid-based delivery of combinations of antisense oligodeoxynucleotides for the in vitro inhibition of HIV-1 replication (Q28366154) ‎ (← links)
• Polyethyleneimine-mediated transfection to improve antisense activity of 3'-capped phosphodiester oligonucleotides (Q30826902) ‎ (← links)
• The spherulites(TM): a promising carrier for oligonucleotide delivery (Q30897989) ‎ (← links)
• Importance of nucleotide sequence and chemical modifications of antisense oligonucleotides (Q33916110) ‎ (← links)
• Oligonucleotides tethered to a short polyguanylic acid stretch are targeted to macrophages: enhanced antiviral activity of a vesicular stomatitis virus-specific antisense oligonucleotide (Q33978043) ‎ (← links)
• Therapies directed against the Rev axis of HIV autoregulation (Q34050702) ‎ (← links)
• Molecular and cellular barriers limiting the effectiveness of antisense oligonucleotides (Q34351307) ‎ (← links)
• Delivery of novel macromolecular drugs against HIV-1. (Q34452681) ‎ (← links)
• Cyclodextrins in oligonucleotide delivery (Q34455188) ‎ (← links)
• Inhibitory effects of (-)-epigallocatechin gallate on the life cycle of human immunodeficiency virus type 1 (HIV-1). (Q34519086) ‎ (← links)
• Innovations in oligonucleotide drug delivery (Q35186336) ‎ (← links)
• Recent advances in delivery systems for anti-HIV1 therapy (Q36761854) ‎ (← links)
• Application of antisense technology to therapeutics (Q38294480) ‎ (← links)
• Anomeric inversion (from beta to alpha) in methylphosphonate oligonucleosides enhances their affinity for DNA and RNA. (Q38332968) ‎ (← links)
• Antisense delivery using protamine-oligonucleotide particles (Q39556532) ‎ (← links)
• Nanoparticle formulation enhances the delivery and activity of a vascular endothelial growth factor antisense oligonucleotide in human retinal pigment epithelial cells (Q40618965) ‎ (← links)
• Down-modulation of TCR/CD3 surface complexes after HIV-1 infection is associated with differential expression of the viral regulatory genes (Q40813351) ‎ (← links)
• Inhibition of inositol uptake in astrocytes by antisense oligonucleotides delivered by pH-sensitive liposomes (Q40887907) ‎ (← links)
• Improved oligonucleotide uptake and stability by a new drug carrier, the SupraMolecular Bio Vector (SMBV). (Q41134788) ‎ (← links)
• Antisense Inhibition of Virus Infections (Q41526944) ‎ (← links)
• Pharmacokinetics and tissue disposition in monkeys of an antisense oligonucleotide inhibitor of Ha-ras encapsulated in stealth liposomes (Q41687773) ‎ (← links)
• New approaches for cancer treatment: antitumor drugs based on gene-targeted nucleic acids. (Q42153007) ‎ (← links)
• Inhibition of HIV replication by immunoliposomal antisense oligonucleotide (Q42552012) ‎ (← links)
• Cell cycle-dependent distribution and specific inhibitory effect of vectorized antisense oligonucleotides in cell culture (Q42813396) ‎ (← links)
• Cationic liposome-encapsulated antisense oligonucleotide mediates efficient killing of intracellular Leishmania (Q42993687) ‎ (← links)
• Inhibition of HIV-1 in cell culture by oligonucleotide-loaded nanoparticles (Q43654284) ‎ (← links)
• Enhanced inhibition of HIV-1 replication in macrophages by antisense oligonucleotides, ribozymes and acyclic nucleoside phosphonate analogs delivered in pH-sensitive liposomes. (Q43741864) ‎ (← links)
• FTIR and UV spectroscopy studies of triplex formation between pyrimidine methoxyethylphosphoramidates alpha-oligodeoxynucleotides and ds DNA targets. (Q44002576) ‎ (← links)
• Liposomes as drug delivery system: a strategic approach for the treatment of HIV infection (Q44473040) ‎ (← links)
• Chimeric alpha-beta oligonucleotides as antisense inhibitors of reverse transcription (Q44999745) ‎ (← links)
• Delivery of antiviral agents in liposomes. (Q45274541) ‎ (← links)
• Attempts to use liposomes and RBC ghosts as vectors in drug and antisense therapy of virus infection (Q45763780) ‎ (← links)
• End-capped antisense oligodeoxynucleotides effectively inhibit gene expression in vivo and offer a low-toxicity alternative to fully modified phosphorothioate oligodeoxynucleotides (Q48672868) ‎ (← links)
• Highly loaded nanoparticulate carrier using an hydrophobic antisense oligonucleotide complex (Q73323687) ‎ (← links)
• Viral targets for antisense oligonucleotides: a mini review (Q74552680) ‎ (← links)